Clorox (NYSE:CLX – Free Report) had its price objective lowered by Barclays from $136.00 to $132.00 in a research report report published on Thursday, Benzinga reports. Barclays currently has an underweight rating on the stock. Other equities analysts have also issued reports about the stock. DA Davidson reiterated a neutral rating and set a $162.00 […] Read this story